Evidence map›Paper›PMID 40292516›Full record

ReviewNutrients2025

Functional Foods, a Hope to Delay Muscle Dystrophy Progression: A Potential Role for Omega Fatty Acids.

Ilaria Versari, Alberto Bavelloni, Mirko Traversari, Sabrina Burattini, Michela Battistelli, Pietro Gobbi, Irene Faenza, Sara Salucci

Abstract readReview
In one paragraph

Review in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ilaria VersariDepartment of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.ORCID 0009-0009-6064-9673
Alberto BavelloniLaboratory of Experimental Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.ORCID 0000-0002-6467-1431
Mirko TraversariDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-6376-7626
Sabrina BurattiniDepartment of Biomolecular Sciences (DiSB), Urbino University Carlo Bo, 61029 Urbino, Italy.
Michela BattistelliDepartment of Biomolecular Sciences (DiSB), Urbino University Carlo Bo, 61029 Urbino, Italy.ORCID 0000-0003-4028-0652
Pietro GobbiDepartment of Biomolecular Sciences (DiSB), Urbino University Carlo Bo, 61029 Urbino, Italy.ORCID 0000-0003-4705-0833
Irene FaenzaDepartment of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-5227-3567
Sara SalucciDepartment of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.ORCID 0000-0002-3507-4451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional foods, thanks to their basic nutritional properties, can have physiological benefits and can alleviate the symptoms of many chronic diseases. They contain active components deriving either from plant or animal sources, and they show anti-inflammatory, cardiotonic, and antioxidant pharmacological activities that could be useful in preventing oxidative damage and inflammatory processes in a variety of disorders. There is evidence from in vitro, in vivo, and clinical observational studies that some compounds have significant effects in modulating the muscular dystrophy phenotype, which is characterized by fibrosis, myofiber necrotic cell death, inflammation, oxidative stress, and dysfunctional mitochondria. This review involves collecting data from the main medical databases and detailing the key features involved in muscular dystrophy progression and the relevance of fatty-acid compounds as diet supplements in the management of the disease. Omega fatty acids improve the dystrophic phenotype in terms of fibrosis and inflammation reduction, stimulating mitochondrial activity and antioxidant systems. Omega fatty acids could play a crucial role as food supplementation to delay dystrophy progression. This overview appears extremely relevant for researchers who are studying these molecules as valid alternatives to glucocorticoids, that today remain the only recognized pharmacological cure for dystrophic patients.

Indexed as

Fatty Acids, Omega-3Functional FoodMuscular DystrophiesAnimalsAntioxidantsDietary SupplementsDisease ProgressionHumansOxidative StressAntioxidantsFatty Acids, Omega-3fibrosisinflammationmuscle dystrophyomega-3 fatty acidsomega-6 fatty acidsoxidative stress

Identifiers

PMID40292516
PMCPMC11944369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.